This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): BA-041
Description: Fentanyl Lauriad is a sustained release formulation of fentanyl utilizing BioAlliance's Lauriad delivery system. Fentanyl targets the opioid receptors acting as an agonist.
Fentanyl Lauriad News
Additional information available to subscribers only: